Planets Sun
Planets Sun
copayimage Restrictionsapply Save now
Skip Navigation LinksHome > Tools and Resources > Race with Insulin®


Meet Charlie Kimball, The First Licensed IndyCar® Driver With Diabetes

Charlie Kimball is a successful young race car driver who has lived and breathed racing since the age of 9 when he began racing go-carts. After high school, he was accepted into Stanford University, but chose to follow his dream of becoming a race car driver.

Kimball has a history of breaking the mold. In 2005, he shattered the European stereotype that "Americans are not fast" by becoming the first American in 11 years to win a British Formula 3 race. He went on to secure 2 track records and several Formula 3 victories in both Britain and other European countries.

Diabetes diagnosis didn’t slow him down

In 2005, at age 22, everything came to a halt when Kimball was diagnosed with type 1 diabetes and had to abandon his racing program midseason. He was afraid that he would never race again, but with the help of his racing crew, his health care team, and diabetes treatment, including NovoLog® FlexPen® (insulin aspart [rDNA origin] injection), he got his diabetes under control and was back in the driver’s seat by 2008. He even claimed a podium finish in his first race since his diagnosis.

Kimball learned the importance of properly managing diabetes and proved that diabetes doesn’t have to stop anyone from accomplishing their dreams.

After 2 successful years in Firestone Indy Lights, Kimball joined the newly formed Novo Nordisk Chip Ganassi Racing team in 2011 for his rookie season in the IZOD IndyCar® Series. Kimball went on to record 2 top-10 finishes in the #83 Novo Nordisk IndyCar® and became the first driver in history with diabetes to qualify, start, and finish the Indianapolis 500.

In January 2013, Charlie impressed his crews on and off the track when he and his teammates won the Rolex 24 relay, his first win in a major touring series. Then in February, Kimball joined with Chip Ganassi Racing Teams to launch the Race with Insulin® Unites program, to support his quest to educate more people with diabetes. On August 4th, he again made history, by becoming the first driver with diabetes to win an IndyCar® race! Charlie took the checkered flag at the Honda Indy 200 at Mid-Ohio, earning his first victory at the highest level of the sport. He also ran second at the Pocono INDYCAR 500 and fourth in the Honda Indy Grand Prix of Alabama. He has been in the top 10 in more than half of his 19 races in 2013.

Preparing for races

Kimball prepares for his races by eating right, exercising, and using NovoLog® FlexPen® to help control his diabetes while managing his insulin delivery routine. On the track, Kimball’s doctor and crew watch his blood glucose levels through a wireless monitoring system attached to his arm. If his levels go too low, he can sip a sugar-infused drink from his helmet to bring them back up. Kimball and his crew rigorously prepare before each race to ensure that his body runs smoothly—just like his car.

Charlie Kimball continues to race in one of the most competitive categories in the world, proving that living with diabetes doesn’t slow him down.

Visit Charlie Kimball’s Web site.

IndyCar® is a registered trademark of Brickyard Trademarks, Inc.

Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Who should not use NovoLog®?

Do not use NovoLog® if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

What should I tell my health care provider before taking NovoLog®?

About all of your medical conditions, including liver, kidney, or heart problems.
If you are pregnant, breastfeeding, or plan to do either.
About all prescription and nonprescription medicines you take, including supplements, as your dose may need to change.

How should I take NovoLog®?

Eat a meal within 5 to 10 minutes after using NovoLog®, a fast-acting insulin, to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after your injection or bolus pump infusion.
Do not mix NovoLog® with any other insulin when used in a pump or with any insulin other than NPH when used with injections by syringe.
Do not change your dose or type of insulin unless you are told to by your health care provider.
Do not share needles, insulin pens, or syringes.
Check your blood sugar levels as directed by your health care provider.

What should I consider while using NovoLog®?

Alcohol, including beer and wine, may affect your blood sugar.
Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your health care provider if you often have low blood sugar or no warning signs of low blood sugar.

What are the possible side effects of NovoLog®?

Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.
Serious allergic reactions may occur. Get medical help right away, if you develop a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.
Other side effects include injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, vision changes, low potassium in your blood, and weight gain.

For more information, please click here for complete NovoLog® Prescribing Information.

NovoLog® is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

Selected Important Safety Information

What are the possible side effects of NovoLog®?

• Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.

• Other side effects include injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, vision changes, low potassium in your blood, and weight gain.

Please click here for additional Important Safety Information

Charlie Kimballʼs story
(3:00 min.)

Individual results may vary.
Pen art

Email to a Friend:

email icon

To(;):

From:

Message: